Search Results - "Hauzenberger, Tanja"

Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial by Shannon, Catherine M, Joly, Florence, Sehouli, Jalid, Canzler, Ulrich, Schmalfeldt, Barbara, Dean, Andrew P, Hein, Alexander, Zeimet, Alain G, Petit, Thierry, Marmé, Frederik, El-Balat, Ahmed, Glasspool, Rosalind, Mahner, Sven, Park-Simon, Tjoung-Won, Mouret-Reynier, Marie-Ange, Costan, Cristina, Reinthaller, Alexander, Goh, Jeffrey C, Kommoss, Stefan, Kurtz, Jean-Emmanuel, Ackermann, Sven, Anthuber, Christoph, Aydogdu, Mustafa, Baldauf, Angelika, Behringer, Dirk, Belau, Antje, Bender, Alexandra, Burges, Alexander, Canzler, Ulrich, Daabach, Trygve, Deryal, Mustafa, El-Balat, Ahmed, Fehm, Tanja, Feisel-Schwickardi, Gabriele, Frank, Matthias, Gebauer, Gerhard, Gerber, Bernd, Gerhardt, Axel, Grafe, Andrea, Griesshammer, Martin, Gropp-Meier, Martina, Hager, Dietrich, Hannig, Carla Verena, Hantschmann, Peer, Harter, Philipp, Hauzenberger, Tanja, Herwig, Uwe, Hilpert, Felix, Jackisch, Christian, Krieger, Peter, Lampe, Björn, Lex, Benno, Lorenz, Ralf, Mahner, Sven, Mallmann, Peter, Marmé, Frederik, Möbus, Volker, Müller, Thomas, Neunhöffer, Tanja, Ober, Angelika, Rautenberg, Beate, Reiter, Wilhelm, Schmalfeldt, Barbara, Scholz, Heinz, Simon, Eike, Sperfeld, Antje, Terhaag, Jürgen, Uleer, Christoph, Vogel, Susanne, Voß, Hermann, Winkler, Ulrich, Wischnik, Arthur, Zorr, Andreas, Glasspool, Ros, Jones, Rachel, Lafleur, Judith, Marth, Christian, Baron-Hay, Sally, Beale, Philip, Begbie, Stephen, Harvey, Sandra, Matos, Marco, Meniawy, Tarek, Olesen, Inger, Shannon, Catherine, Abadie-Lacourtoisie, Sophie, Arsene, Olivier, Barthier, Sophie, Catala, Stéphanie, Dohollou, Nadine, Garnier-Tixidré, Claire, Guardiola, Emmanuel, Hardy-Bessard, Anne-Claire, Joly, Florence, Levache, Charles-Briac, Longo, Raffaele, Lortholary, Alain, Meunier, Jérôme, Raban, Nadia, Vannetzel, Jean-Michel

“…State-of-the art therapy for recurrent ovarian cancer suitable for platinum-based re-treatment includes bevacizumab-containing combinations (eg, bevacizumab…”
Get full text

Laparoscopic Removal of a Dislocated Screw of a Hip Joint Endoprosthesis during Oncologic Surgery by Halder, Christina, Hauzenberger, Tanja, Scharl, Anton, Bauer, Robert, Papathemelis, Thomas

Get full text

Sentinel Lymph Node Biopsy in Breast Cancer Patients by Means of Indocyanine Green Using the Karl Storz VITOM® Fluorescence Camera by Scharl, Sophia, Klinkhammer-Schalke, M., Gerken, Michael, Hauzenberger, Tanja, Scharl, A., Jablonski, Evi, Papathemelis, Thomas, Hipp, Matthias

“…Currently, the use of radioisotope and blue dye for sentinel lymph node biopsy (SLNB) for axillary staging in breast cancer is common. Recently, indocyanine…”
Get full text

Efficacy of Endocrine Therapy for the Treatment of Breast Cancer in Men: Results from the MALE Phase 2 Randomized Clinical Trial by Reinisch, Mattea, Seiler, Sabine, Hauzenberger, Tanja, Kamischke, Axel, Schmatloch, Sabine, Strittmatter, Hans-Joachim, Zahm, Dirk-Michael, Thode, Christian, Furlanetto, Jenny, Strik, Dominika, Möbus, Volker, Reimer, Toralf, Sinn, Bruno Valentin, Stickeler, Elmar, Marmé, Frederik, Janni, Wolfgang, Schmidt, Marcus, Rudlowski, Christian, Untch, Michael, Nekljudova, Valentina, Loibl, Sibylle

“…The extent of changes in estradiol levels in male patients with hormone receptor-positive breast cancer receiving standard endocrine therapies is unknown. The…”
Get more information

Prospective cohort study using the breast cancer spheroid model as a predictor for response to neoadjuvant therapy--the SpheroNEO study by Halfter, Kathrin, Ditsch, Nina, Kolberg, Hans-Christian, Fischer, Holger, Hauzenberger, Tanja, von Koch, Franz Edler, Bauerfeind, Ingo, von Minckwitz, Gunter, Funke, Ilona, Crispin, Alexander, Mayer, Barbara

“…Aim of this prospective study was to predict response to neoadjuvant therapy in breast cancer patients using an in vitro breast cancer spheroid model…”
Get full text

Abstract P3-06-13: Prospective cohort study using the breast cancer spheroid model as a predictor for response to neoadjuvant therapy – The SpheroNEO study by Halfter, Kathrin ML, Ditsch, Nina, Kolberg, Hans-Christian, Fischer, Holger, Hauzenberger, Tanja, Edler von Koch, Franz, Bauerfeind, Ingo, von Minckwitz, Gunter, Funke, Ilona, Crispin, Alexander, Mayer, Barbara

“…(1) PURPOSE The aim of the prospective trial was to determine if cell survival in a breast cancer spheroid model following cytostatic treatment in vitro…”
Get full text

A randomized phase III trial comparing nanoparticle-based paclitaxel with solvent-based paclitaxel as part of neoadjuvant chemotherapy for patients with early breast cancer (GeparSepto): GBG 69 by Jackisch, Christian, Wiebringhaus, Frank, Conrad, Bettina, Weigel, Michael, Aktas, Bahriye, Wagner, Harald, Latos, Kunibert, Kohls, Andreas, Bueckner, Ute, Hauzenberger, Tanja, Bangemann, Nikola, Hackmann, John, Clemens, Michael R., Heinrich, Bernhard, Tome, Oliver, Loibl, Sibylle, Nekljudova, Valentina, Von Minckwitz, Gunter

“…Abstract only TPS1141 Background: Anthracyclines (A) followed by taxanes (T) are standard of care for neoadjuvant therapy in breast cancer (BC). A reverse…”
Get full text

Financing of certified centers: a willingness-to-pay analysis by Thiel, Falk C., Scharl, Anton, Hildebrandt, Thomas, Kotziabassis, Efstratios, Schrauder, Michael G., Bani, Mayada R., Müller, Andreas, Hauzenberger, Tanja, Loehberg, Christian R., Jud, Sebastian M., Fasching, Peter A., Hartmann, Arndt, Schulz-Wendtland, Rüdiger, Strnad, Vratislav, Beckmann, Matthias W., Lux, Michael Patrick

“…Introduction Although care in certified breast centers is now established throughout Germany, numerous services are still not being reimbursed. This also…”
Get full text